Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

PolyPid (Israel) a development-stage biotechnology company focused on polymers and lipid-based systems for drug delivery and biodegradable bone void fillers, closed a $2M Series B financing. Participants include Xenia Venture Capital.

Arsenal Medical (Watertown, MA) a development-stage biotech company focused on nanofiber drug delivery and therapeutic foams to accommodate complex anatomies,closed $3M Series A financing. Participants include Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners.

480 Biomedical (Waltham, MA) a development-stage biopharmaceutical company focused on bioresorbable scaffold for treating occlusive disease in the femoral artery, closed $15M Series A financing. Participants include Polaris Venture Partners, North Bridge Venture Partners and Intersouth Partners.

Leonardo Biosystems (Houston, TX) a development-stage biopharmaceutical company focused on drug delivery technology, closed a $1.25M Series A financing, bringing the total round to $2.5M. Participants include Texas Emerging Technology Fund.

SpringLeaf Therapeutics (Boston, MA) a preclinical-stage biopharmaceutical company focused on novel delivery mechanisms, closed a $4M Series B financing, bringing the total round to $19M. Participants include Excel Venture Management, SR One, Flybridge Capital Partners and North Bridge Venture Partners. Thanx for your patience as we catch-up.

  

to top of page...